Cardiovascular disease must be “prioritised” and made a “key factor” in the management of type 2 diabetes, according to researchers from a major study. The findings ...
A call for just two diabetes nursing titles has been made after the results of the first-ever, England-wide Diabetes Specialist Nurse (DSN) Audit revealed there were 117 job titles. The survey ...
Greater Manchester has become the second city in the UK to join a global initiative to “fight” type 2 diabetes in urban locations. It was announced as the 22nd city to join Novo ...
A new version of a digital programme designed to help educate people with diabetes and healthcare professionals about how to manage the risks and challenges of hypoglycaemia has been launched. ...
Ozempic®(semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of type 2 diabetes, is now available in the UK, Novo Nordisk UK has announced. It works by mimicking the ...
Novo Nordisk has issued a pharmacy level recall for Fiasp® FlexTouch® batch number HP50949. The recall was initiated as some Fiasp® FlexTouch® from this batch might contain particles. In ...
Leicester has become the first UK city to join a global campaign to raise awareness of and prevent type 2 diabetes. A city-wide campaign is being launched as part of a global programme to raise ...
A medical safety alert involving a greater risk of hypoglycaemia has been issued about a specific brand of insulin pen. The Medicines and Healthcare Products Regulatory Agency has released ...
A free webinar looking at hypoglycaemia in type 2 diabetes and how it impacts people will take place ahead of a major healthcare professional conference. Dr Nicole Braham, who is a diabetes ...
Healthcare providers are being urged to warn people that an insulin cartridge holder used in a number of pens has been found to be faulty. Novo Nordisk, the company which makes the recalled ...